The Women’s Health Clinical Training Program Field Specialists (CTPFS) will execute and manage event types as designed within the Clinical Training Programs (CTPs), which provide an innovative way to meet the unmet needs in the current training model. This role will be guided by all activities and policies as outlined in the Reference Manual for CTPs. This includes collaboration with women's health professionals, academic centers, organizations and business partners with the following goals. The CTP was developed by Organon, LLC to ensure that health care professionals receive instructions and training on the procedures entailed in the use of our birth control implant product. Only licensed healthcare professionals, who have completed the training program, are eligible to order the product. The objective of the CTP is to instruct healthcare professionals on a review of the prescribing label as well as hands on simulation of the insertion, localization, removal and reinsertion of our birth control implant product. This role will be responsible for executing regulatory guidelines governing CTP such as disclosure that the program was developed, and trainers engaged by Organon. Organon delivers ingenious health solutions that enable people to live their best lives. We are a $6.5 billion global healthcare company focused on making a world of difference for women, their families and the communities they care for. We have an important portfolio and are growing it by investing in the unmet needs of Women’s Health, expanding access to leading biosimilars and touching lives with a diverse and trusted portfolio of health solutions. Our Vision is clear: A better and healthier every day for every woman. At Organon, we aspire to improve the lives of people globally by unleashing the promise of trusted brands across women’s health and other important therapeutic areas. We are committed to becoming the world’s leading women’s health company investing in innovations that support women’s wellbeing. Fueled by its leading contraceptives and fertility businesses, Organon will invest in innovations that support the distinct health care needs of women today. Organon will also focus on its important biosimilars business, focusing on oncology and inflammatory diseases, while also maximizing the value of its trusted dermatology, pain, respiratory and cardiovascular portfolio in countries around the world where there is still great need for these treatments.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
5,001-10,000 employees